Transdiscal administration of anti-TNFα antibodies and growth differentiation factors
US8877193B2 · kind B2 · utility
1Cited by
53References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2008 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Jun 29, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.